uracil has been researched along with Brain Disorders in 2 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, K | 1 |
| Nukui, A | 1 |
| Kobayashi, M | 1 |
| Sugaya, Y | 1 |
| Muraishi, O | 1 |
| Morita, T | 1 |
| Tokue, A | 1 |
| Ikeda, K | 1 |
| Kumada, H | 1 |
| Arase, Y | 1 |
| Chayama, K | 1 |
| Gunji, T | 1 |
| Yoshiba, A | 1 |
| Irimoto, M | 1 |
1 review available for uracil and Brain Disorders
| Article | Year |
|---|---|
[A case of pulmonary metastasis from renal cell carcinoma with complete response to interferon-alpha and tegafur/uracil (UFT) but possibly UFT-induced liver dysfunction and leukoencephalopathy-like symptoms].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carcinoma, Renal Cell; Chemical and | 1999 |
1 other study available for uracil and Brain Disorders
| Article | Year |
|---|---|
[Risk factors for side effects of long-term administration of 5-fluorouracil derivatives in patients with hepatocellular carcinoma associated with liver cirrhosis--relationship with serum concentration of anti-tumor agents and side effect].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Brain Diseases; Carcinoma, Hepatocell | 1988 |